IGFBP4 Antikörper (AA 22-258)
Kurzübersicht für IGFBP4 Antikörper (AA 22-258) (ABIN7569771)
Target
Alle IGFBP4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 22-258
-
Verwendungszweck
- Anti-IGFBP4 Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human IGFBP4 (Asp22-Glu258).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Andere Bezeichnung
- IGFBP4
-
Hintergrund
- IGF-binding protein 4,IBP-4,Insulin-like growth factor-binding protein 4,IGFBP-4,IGFBP4,IBP4,
-
UniProt
- P22692
-
Pathways
- WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
Target
-